Atlas Trials

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

Clinical trial NCT07302763 · RECRUITING

Trial details

NCT number
NCT07302763
Sponsor
Frederic Pouliot
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Start date
2025-11-04
Primary completion
2029-12-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.